NeuroMind AGI is a DeepTech company operating at the intersection of artificial intelligence and neuroscience, focused on the objective assessment and early identification of cognitive and mental states.

The company develops a software-only AI platform that analyzes neurophysiological signals (including EEG), cognitive responses and behavioral patterns to generate real-time cognitive indicators, risk scores and diagnostic decision-support outputs. NeuroMind’s technology is designed exclusively for assessment and early identification, and does not provide therapeutic or treatment interventions.

NeuroMind operates with a dual-use model across multiple domains.

In healthcare, the platform supports clinicians, occupational physicians and research institutions by enabling the objective assessment of stress-related and neuropsychiatric risk profiles, improving diagnostic accuracy and decision-making while remaining aligned with medical device regulatory frameworks.

In defense and security, NeuroMind assesses cognitive readiness and mental resilience of personnel operating in high-stress and mission-critical environments, such as military operators and cyber-defense teams, helping identify cognitive fatigue, overload and early warning signals of impairment.

NeuroMind also addresses cyber-cognitive security, enhancing resilience against cognitive overload, disinformation pressure and psychological stressors in complex operational environments.

In pharma and biotech, the platform functions as a digital biomarker engine, supporting clinical trials, neuropsychiatric research and drug-response monitoring through objective, AI-driven cognitive and neurophysiological indicators.

More broadly, NeuroMind enables organizations to measure the real cognitive impact of work, organizational change and AI adoption, supporting the transition from digital transformation to cognitive transformation and enabling innovation without exhausting the human mind.

Neuromind AGI

Org chart

Teams

Offices